Andrew Tatarsky, Ph.D., Founder and Director The Center for Optimal Living will take us through a harm reduction approach which has compassion at its centre. This webinar looks at harm reduction across the range of risk behaviours associated with problematic use of substances.
This Inside Health podcast discusses why vaping is dividing public health experts causing a polarised split; prehabilitation before cancer surgery and the benefits of preparing for an operation; plus can hospital safety be compared to lessons learnt from the aviation industry?
The Virtual Library in Addictions, developed by Centros de Integración Juvenil, allows access to resources and information services specialized in Addictions and related topics, serving users of different levels.
El Observatorio Mexicano de Drogas tiene como propósito brindar información objetiva, confiable y comparable a nivel nacional sobre el consumo de sustancias psicoactivas y la demanda de tratamiento por su uso para orientar el diseño de políticas públicas.
Xchange is an online registry of evidence-based prevention programmes. In its first phase, the registry will make available manualised interventions that European evaluation studies show have beneficial outcomes relating to substance use. For programmes of US origin, the registry also provides the evidence level of the evaluation studies conducted there (Blueprint ratings).
The term “comorbidity” describes two or more disorders or illnesses occurring in the same person. They can occur at the same time or one after the other. Comorbidity also implies interactions between the illnesses that can worsen the course of both.
Many individuals who develop substance use disorders (SUD) are also diagnosed with mental disorders, and vice versa.
Canadian alcohol intake increases during holidays, parties and vacations.
The Canadian Centre on Substance Use and Addictions has created a calendar of social media graphics to remind young people that if they’re planning to drink, moderation can help reduce harms from alcohol.
In classrooms across the UK 1 in 5 children are carrying the burden of someone else’s drinking.
The National Association for Children of Alcoholics have developed a new resource to help teachers identify children affected by their parent's alcohol consumption.
MDMA (Methylenedioxymethamphetamine) is a synthetic drug that alters mood and perception (awareness of surrounding objects and conditions). MDMA was initially a common nightlife drug, but it affects a broader range of people.
Barely a week goes by without legal highs, binge drinking, or the latest celebrity rehab hitting the headlines.
But have you ever wondered what the facts are behind drug and addiction news stories?
The Improving Outcomes in the Treatment of Opioid Dependence (IOTOD) Take-Home Naloxone Toolkit contains guidance and resources on how to set up a take-home naloxone programme, in order to reduce overdoses and save lives.
Improving Outcomes in the Treatment of Opioid Dependence (IOTOD) is an educational initiative that aims to improve opioid dependence healthcare through a variety of programmes
Webinar: Prevention Science and Its Application to Substance Use Prevention Interventions and Policy
Zili Sloboda, Sci.D, President of Applied Prevention Science International presents Prevention Science and Its Application to Substance Use Prevention Interventions and Policy: The Role of Universities.
Parental problem alcohol and other drug use are associated with social, legal, economic and health-related problems. It can disrupt family routines and responsibilities, relationships with relatives and friends, and the family’s social circumstances and social status.
Drug-related deaths are the highest they have ever been. We know that medication-assisted treatments (MAT), such as the prescription of methadone and buprenorphine, are our most powerful interventions. Supporting opioid-dependent service users to begin MAT at the earliest and safest opportunity saves lives.
Many healthcare providers report that addressing alcohol and other drug problems is one of the most challenging areas of their practice. Providers are unsure how to address these issues, and yet they are in a prime position to reduce the negative outcomes related to substance misuse.
Supporting a friend, partner, or family member affected by problematic alcohol or drug use can be difficult.
This webinar focuses on:
Overcoming organisational and cultural issues
Stabilisation and assisted withdrawal
Retox and continuity of care
Dr Joss Bray, Clinical Lead for Drug and Alcohol Treatment in the North East Prisons for Spectrum CIC.
The Cochrane Drugs and Alcohol Group specialises in reviews that assess, among other things, ways to reduce hazardous or harmful drinking of alcohol.
One of these reviews looks at the evidence on practitioner-delivered brief interventions and we asked one of the authors, Fiona Beyer from Newcastle University in the UK to tell us about the findings from the update in February 2018.
This website offers resources developed from a two-year research programme on end of life care for people with alcohol and other drug problems.
The vast majority of the countries in the European Union prohibit the production, sale, possession, and use of pharmaceutical-grade herbal cannabis. However, most EU countries allow cannabis-based medicine, such as Sativex, to be prescribed in certain circumstances.
The Society for the Study of Addiction (SSA) has made available a selection of presentations that were delivered at the SSA Annual Conference in 2018.
The International Consortium of Universities for Drug Demand Reduction (ICUDDR) ran multiple sessions during the joint NACADA, ISSUP and African Union Drug Demand Reduction Conference & Workshop
The Canadian Centre on Substance Use and Addiction (CCSA) has produced a new series of podcasts that are investigating and reviewing the evidence on alcohol, cannabis, opioids, stigma and more.